Results 71 to 80 of about 712 (172)

A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics. [PDF]

Biology (Basel), 2023
Banushi B, Polito V.
europepmc   +1 more source

The renaissance of research on psychedelics in child and adolescent psychopharmacology. [PDF]

Child Adolesc Psychiatry Ment Health
Crocq MA, Auby P.
europepmc   +1 more source

Effects of combined metformin and cabergoline versus metformin alone on inflammatory markers in Iraqi patients with PCOS and hyperprolactinemia: a randomized clinical trial. [PDF]

J Med Life
Hamad IN, Kadhim SAA, Bassim M, Asma S, Adnan FH.   +4 more
europepmc   +1 more source

EFFECTS OF ERGOLINES ON DOPAMINERGIC AND SEROTONERGIC SINGLE UNIT ACTIVITY

, 1979
M.D. BARING, J.M. LAKOSKI, J.R. WALTERS
core   +1 more source

Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action. [PDF]

Pharmacol Res Perspect
Kazdan J, Ladha KS, Husain MI.
europepmc   +1 more source

5-HT_2A receptors: Pharmacology and functional selectivity. [PDF]

Pharmacol Rev
Cummins BR, Billac GB, Nichols DE, Nichols CD.   +3 more
europepmc   +1 more source

Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics. [PDF]

ACS Chem Neurosci
Bhat A, Zolali E, Sakib MA, Rahimian M, McMahon LR, German N, Obeng S.   +6 more
europepmc   +1 more source

)‐6‐(Propyloxy)ergolines from the 6‐Methyl Precursors

, 1986
René Nordmann, Peter Gull
core   +1 more source

Prolactinomas treated with dopaminergic agonists: behavior in different moments of life. [PDF]

Rev Bras Ginecol Obstet
Carneiro MS, Garmes HM, Pravatta-Rezende G, de Mira TAA, Yela DA, Benetti-Pinto CL.   +5 more
europepmc   +1 more source

Molecular and Medical Aspects of Psychedelics. [PDF]

Int J Mol Sci, 2023
Wojtas A, Gołembiowska K.
europepmc   +1 more source